The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Planned interim analysis of PATRICIA: An open-label, single-arm, phase II study of pertuzumab (P) with high-dose trastuzumab (H) for the treatment of central nervous system (CNS) progression post radiotherapy (RT) in patients (pts) with HER2-positive metastatic breast cancer (MBC).
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; GlaxoSmithKline; Kadmon; Novartis; Oncothyreon
 
Alisha Stein
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Alan Nicholas
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Anita M. Fung
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Priya Kumthekar
No Relationships to Disclose
 
Nuhad K. Ibrahim
No Relationships to Disclose
 
Mark D. Pegram
Employment - Dava Oncology (I)
Consulting or Advisory Role - AstraZeneca; Genentech; Novartis; Pfizer
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Genentech; Novartis; Pfizer
Other Relationship - AstraZeneca; Genentech; Novartis; Pfizer